Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

#18-2174 Listing of Mini futures issued by Vontobel Financial Products GmbH

As from November 19, 2018, 3 Mini futures issued by Vontobel Financial Products GmbH will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: Vontobel Financial Products GmbH Type of security: Mini futures, open ended Execution: Automatic cash settlement Term: As from November 19, 2018 and forward or until time for knock out event Market Maker: Bank Vontobel Europe AG Underlying: Hennes & Mauritz AB, H & M ser. B Silver (troy ounce) Current values of strike and barrier can be found

Dome Energy announces that it has realized hedge profits of ~$1mm in November 2018

Dome Energy AB  (publ) (herein after “Dome” and/or “the Company”) announces that it has realized hedge profits of ~$1mm in November 2018.  Paul Morch, CEO: “During the month of October we sold contracts for 76,000 barrels of oil at ~$71 per barrel, with delivery through 2019. The recent unforeseen drop in oil prices have given us an opportunity for short term profits, and we decided to sell these hedges now. The profit will affect our fourth quarter numbers. Gas prices have increased almost 50% recently to levels not seen in a long time. We have added hedges

ProTrans trial is approved for high dose treatment in the phase II part

The stem cell company NextCell Pharma AB ("NXTCL") today announced that the Swedish Medical Product Agency has approved the amendment for treatment of patients in the ProTrans-1 trial with high dose of ProTrans in the randomized placebo-controlled part.The ProTrans clinical trial is divided into a dose-scale part where 9 patients were treated with ProTrans during 2018. On October 25th, the Data Safety and Monitoring Board recommended the start of the second part of the trial with the dose that the study team found most appropriate. The safety of ProTrans seem well tolerated, NXTCL

EQL Pharma’s rights issue subscribed to approximately 161.7 percent

NOT FOR DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, HONG KONG, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL.The subscription period for the rights issue in EQL Pharma AB (publ) (“EQL Pharma” or the “Company”) ended on November 13th, 2018 and the summary shows that the rights issue was subscribed to approximately 161.7 percent. Subscription by exercise of subscription rights amounted to approximately 99.

Holding(s) in Company

TR-1: Standard form for notification of major holdings NOTIFICATION OFMAJOR HOLDINGS (to be sent to therelevant issuerand tothe FCA inMicrosoft Wordformat   ifpossible)i 1a. Identity of Enquest PLCthe issuer or theunderlying issuerof   existingshares to whichvoting rights areattachedii:  1b. Pleaseindicate if theissuer isa non-UK   issuer (please mark withan   "X" ifappropriate)Non-UK issuer2. Reason for thenotification(please   mark theappropriate box orboxes with an "X")An acquisition or

Instalco grows in Finland

Instalco strengthens its position in Finland via the acquisition of Twinputki Oy, a company with specialist expertise in automatic sprinkler systems.Twinputki Oy is situated in Kerava, near Helsinki. It was founded in 2005 and it currently has about ten direct employees. The company has operations throughout Finland, but its focus is Helsinki, Tampere and the surrounding areas. For the 2017/2018 business year, sales were approximately SEK 28 million. “Twinputki is an expert in automatic sprinkler systems and it will strengthen our position in the heating & plumbing sector in Finland. The

Macedonian Cannabis Operation Standardizes on Heliospectra LED Grow Light Solutions

(GOTHENBURG, Sweden / SAN FRANCISCO, CA, November 16, 2018) – Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announces a new order from F&M 2017 DOO. The company is starting a new state-of-the-art medicinal cannabis facility in Macedonia, and has chosen to standardize on Heliospectra’s solutions to fully automate their lighting environment and provide highest quality pharmaceutical products. The order is for Heliospectra’s fully adjustable spectrum ELIXIA LED grow lights and

Extraordinary General Meeting in Saab was held on 16 November 2018 in Stockholm

Saab held an Extraordinary General Meeting on 16 November, at Norra Latin in Stockholm. The Extraordinary General Meeting decided on authorisation for the Board of Directors to resolve on issue of new shares.The Extraordinary General Meeting decided in accordance with the Board’s proposal to authorise the Board of Directors to resolve on issue of new shares with a preferential right for the Company’s shareholders at one or several occasions during the period up to the Company’s Annual General Meeting in 2019. The total number of shares that may be issued by virtue of the authorisation shall

BAKKAFROST: Temporary closure of FO 125 Glyvrar to export to Russia

Russian authorities Rosselkhoznadzor have imposed restrictions on import from AUT 125 Glyvrar. The stated reason is found of some bacteria in a sample of off cuts, that was imported to Russia. Faroese Food Authorities Heilsufrøðisliga Starvsstova will inspect and go through all documentation at the factory AUT 125 today and respond to Russelkoznador next week. The consequence of the issue is that export of off cuts to Russia from Aut 125 Glyvrar will stop from 23 November 2018 until further decision has been taken. Bakkafrost will be able to reallocate our sales to other markets.

Notice Convening an Extraordinary General Meeting 2018

ANNOUNCEMENT NO. 15 - 16 NOVEMBER 2018 Notice is hereby given that an extraordinary general meeting will convene in Dampskibsselskabet NORDEN A/S at 2.00 p.m. on Wednesday 12 December 2018, at the Company’s address 52, Strandvejen, DK-2900 Hellerup. As the general meeting is expected to be brief, no meal will be served. AGENDA: A.         Election of members to the Board of Directors.                  The Board of Directors proposes election of:             1. Helle Østergaard Kristiansen             2. Stephen John Kunzer If elected at the extraordinary

Notice of Extraordinary General Meeting in Net Gaming Europe AB (publ)

The shareholders of Net Gaming Europe AB (publ), company. reg. no. 556693-7255, are hereby convened to the extraordinary general meeting on Monday 17 December 2018 at 10:00 at the offices of Advokatfirma DLA Piper on Kungsgatan 9 in Stockholm.Notification etc.Shareholders who wish to participate at the general meeting shall i) be registered in the share register kept by Euroclear Sweden AB Tuesday 11 December 2018 as well as ii) notify the Company in writing of their intention to participate at the general meeting no later than by Tuesday 11 December 2018 at 16:00 to Net Gaming Europe AB (

3Shape TRIOS MOVE wins Innovation of the Year Award in the UK

Copenhagen, November 16, 2018 – 3Shape TRIOS MOVE , the latest version of the award-winning 3Shape TRIOS intraoral scanner, gains new honor, “Innovation of the Year” at the UK’s FMC Dental Industry Awards. The awards presented by the FMC media company in-conjunction with the British Dental Industry Association (BDIA) made the announcement at their awards ceremony held last night in London, UK, (November 15). 3Shape TRIOS MOVE beat out seven other short-listed solutions to win the “Innovation of the Year” award. The FMC panel deemed the

Financial Statements Q3 2018

OKEA AS Total operating income for the third quarter 2018 was NOK 134.9 million, compared to NOK 8.7 million in the same period last year. This includes income of NOK  115 million relating to the Yme insurance settlement. Profit from operating activities were NOK 75.5 million (-13.1). Net loss for the third quarter was -64.4 (-6.4). Related to bond terms for OKEA01, the tax/shelter ratio was 1.41 for Q3 2018. Following the Shell transaction, the board of directors in OKEA are of the opinion that the company is well positioned for further growth, both organic and inorganic. The company

Announcement pursuant to the Securities Act, Chapter 9, Section 5: Ownership of Ilkka-Yhtymä Oyj in Alma Media Corporation

Alma Media Corporation     Stock Exchange Release   16 November 2018  ANNOUNCEMENT PURSUANT TO THE SECURITIES ACT, CHAPTER 9, SECTION 5: OWNERSHIP OF ILKKA-YHTYMÄ OYJ IN ALMA MEDIA CORPORATION Alma Media Corporation has received a notification on November 16, 2018, pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act, that Ilkka-Yhtymä Oyj’s holding of the shares and votes in Alma Media has decreased under the threshold of 15%. Issuing company and its business ID: Alma Media Corporation, 1944757-4 Complete name and business ID of the shareholder: Ilkka-Yhtymä

Announcement pursuant to the Securities Act, Chapter 9, Section 5: Ownership of Otava Oy in Alma Media Corporation

Alma Media Corporation     Stock Exchange Release 16 November 2018 ANNOUNCEMENT PURSUANT TO THE SECURITIES ACT, CHAPTER 9, SECTION 5: OWNERSHIP OF OTAVA OY IN ALMA MEDIA CORPORATION Alma Media Corporation has received a notification on November 16, 2018, pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act, that Otava’s holding of the shares and votes in Alma Media has exceeded the threshold of 25%. Issuing company and its business ID: Alma Media Corporation, 1944757-4 Complete name and business ID of the shareholder: Otava Oy, 0822255-6 Basis of

Episurf Medical to present at Redeye Life Science Day, held in Stockholm, November 21

Episurf Medical will present at Redeye Life Science Day, a small-cap investor conference, held in Stockholm on November 21 (Haymarket by Scandic). The event is arranged by Redeye and the company will be represented by CEO Pål Ryfors. The presentation will be available on the company’s website after the presentation. For full program and registration, see link. For more  information, please contact:  Pål Ryfors, CEO, Episurf MedicalTel:+46 (0) 709 62 36 69Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is

Insider transaction in Episurf Medical

Board member Laura Shunk has on 14 November 2018 bought 20,000 B-shares in Episurf Medical. Laura Shunk now owns 40,750 Class B-shares. For more  information, please contact:  Pål Ryfors, CEO, Episurf MedicalTel:+46 (0) 709 62 36 69Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalised treatment alternatives. Episurf Medical’s Episealer® personalised implants and Epiguide® surgical drill guides are developed

Inhalation Sciences to present at Redeye Life Science Day, November 21 Stockholm

Inhalation Sciences’ CEO Lena Heffler’s presentation will also be streamed live. “The world-leading control and precision of our technology means lung scientists save crucial time and money in essential early-stage research. I look forward to showing investors how far we’ve already come.”The event will take place at Haymarket by Scandic, Hötorget in central Stockholm. Lena Heffler’s presentation will be in Sal 2, 08.20-08.40. All presentations at Redeye Life Science Day will be streamed live, beginning at 08.10. They can be followed on smartphone or computer at www.redeye.se/live/lsday-

Flexion Mobile Plc announces issue of US patent

Company is awarded patent for key aspects of its core technology in the USLondon, 16th of November, 2018 - Flexion Mobile Plc (“NASDAQ:FLEXM”), the London-based company that helps game developers maximise the growth potential of their Android games, today announced that the USPTO has issued patent no 10,127,035. The patent - SYSTEM AND METHOD TO MODIFY RUN-TIME BEHAVIOR OF AN APPLICATION BY MODIFICATION OF MACHINEREADABLE INSTRUCTIONS -  covers integral aspects of the technology that powers Flexion’s service offering. Jens Lauritzson, CEO of Flexion Mobile, commented: “We are proud

Nordic Nanovector ASA: Increased share capital following exercise of employee share options

Oslo, Norway, 16 November 2018. A individual participant in Nordic Nanovector ASA's (the "Company") (OSE:NANO) previous share option program, not being a primary insider, has exercised a total number of 300,000 options through exercise of a corresponding number of free-standing warrants. 185,421 of the options are exercised at a strike price of NOK 25 per share, and 114,579 of the options are exercised at a strike price of NOK 14.24 per share. Each free-standing warrant gives the right to receive one share in the Company. Following exercise of the 300,000 free-standing warrants, the

Axactor adds another forward flow agreement with a new client in Norway

Oslo, November 16th 2018 Axactor Norway has complemented their existing forward flow agreements, by adding a new large financial institution to the list of clients it acquires fresh NPL volumes from. The contract period is 18 months, with an option to extend for a further 6 months. The total expected outstanding balance sold will be up to 22 mEUR across 12.500 claims. “Norway continues to succeed in adding new volumes from high quality sellers. This contract when combined with the existing volumes, will help us to deliver significant growth in Norway in 2019.” says Stina Koren,

Basware response to media speculation

Basware Corporation, stock exchange release, November 16, 2018 at 11:05 a.mBasware refers to the recent media speculation about a takeover approach and confirms that it has been approached with a non-binding and highly conditional indicative proposal for a possible tender offer for the entire share capital of Basware (the “Indicative Proposal”). The Indicative Proposal is subject to a number of pre-conditions including, but not limited to, securing of appropriate financing, satisfactory completion of due diligence and a recommendation from the Board of Directors of Basware. Completion of

Resurs Bank planning to sell delinquent receivables

Resurs Bank, a wholly owned subsidiary of Resurs Holding, has entered into forward flow agreements with credit management companies Alektum Group, Axactor and Lowell, enabling them to recover some of the bank’s delinquent receivables in Sweden and Norway. The first transfer is expected to take place in January 2019. The transfers are expected to have a positive impact on Resurs Bank’s capital requirements, liquidity and earnings.Some of Resurs Bank’s receivables that are more than 120 days past due will be sold to the credit management companies. The total quantity of outstanding debt

There are no items matching the current filter
There are no more items matching the current filter
Back to top